| Dr Bennett Peter Scaglia, MD | |
|
311 N Clyde Morris Blvd, Suite 360, Daytona Beach, FL 32114-2781 | |
| (386) 254-4199 | |
| (386) 947-4680 |
| Full Name | Dr Bennett Peter Scaglia |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 37 Years |
| Location | 311 N Clyde Morris Blvd, Daytona Beach, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003880626 | NPI | - | NPPES |
| .36088435 | Medicaid | IL | |
| 5007705 | Other | IL | BLUE CROSS/BLUE SHIELD IL |
| 000954100 | Medicaid | FL |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventhealth Daytona Beach | Daytona beach, FL | Hospital |
| Adventhealth Orlando | Orlando, FL | Hospital |
| Halifax Health Medical Center | Daytona beach, FL | Hospital |
| Adventhealth New Smyrna Beach | New smyrna beach, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Florida Clinical Practice Association | 0345146254 | 1636 |
| Memorial Health Systems Inc | 9739081142 | 79 |
News Archive
A Michigan State University public health researcher is embarking on a first-of-a-kind study that will look to reduce suicides among recently released jail detainees.
The Green Bay CBS affiliate is reporting that the "Better Business Bureau is putting out an alert about health insurance related scams." Scammers have been more active since the health bill passed.
The Observer on Tuesday published a series of feature articles examining family planning in Uganda.
Cell Therapeutics, Inc. (CTI) today announced an agreement with the North Central Cancer Treatment Group (NCCTG) to conduct a phase II study of pixantrone in patients with HER2-negative metastatic breast cancer who have tumor progression after at least two, but not more than three, prior chemotherapy regimens.
› Verified 2 days ago
| Entity Name | Florida Clinical Practice Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063463768 PECOS PAC ID: 0345146254 Enrollment ID: O20031211000099 |
News Archive
A Michigan State University public health researcher is embarking on a first-of-a-kind study that will look to reduce suicides among recently released jail detainees.
The Green Bay CBS affiliate is reporting that the "Better Business Bureau is putting out an alert about health insurance related scams." Scammers have been more active since the health bill passed.
The Observer on Tuesday published a series of feature articles examining family planning in Uganda.
Cell Therapeutics, Inc. (CTI) today announced an agreement with the North Central Cancer Treatment Group (NCCTG) to conduct a phase II study of pixantrone in patients with HER2-negative metastatic breast cancer who have tumor progression after at least two, but not more than three, prior chemotherapy regimens.
› Verified 2 days ago
| Entity Name | Halifax Healthcare Systems Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245283530 PECOS PAC ID: 1254238090 Enrollment ID: O20031218000443 |
News Archive
A Michigan State University public health researcher is embarking on a first-of-a-kind study that will look to reduce suicides among recently released jail detainees.
The Green Bay CBS affiliate is reporting that the "Better Business Bureau is putting out an alert about health insurance related scams." Scammers have been more active since the health bill passed.
The Observer on Tuesday published a series of feature articles examining family planning in Uganda.
Cell Therapeutics, Inc. (CTI) today announced an agreement with the North Central Cancer Treatment Group (NCCTG) to conduct a phase II study of pixantrone in patients with HER2-negative metastatic breast cancer who have tumor progression after at least two, but not more than three, prior chemotherapy regimens.
› Verified 2 days ago
| Entity Name | Memorial Health Systems Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922115914 PECOS PAC ID: 9739081142 Enrollment ID: O20040730000409 |
News Archive
A Michigan State University public health researcher is embarking on a first-of-a-kind study that will look to reduce suicides among recently released jail detainees.
The Green Bay CBS affiliate is reporting that the "Better Business Bureau is putting out an alert about health insurance related scams." Scammers have been more active since the health bill passed.
The Observer on Tuesday published a series of feature articles examining family planning in Uganda.
Cell Therapeutics, Inc. (CTI) today announced an agreement with the North Central Cancer Treatment Group (NCCTG) to conduct a phase II study of pixantrone in patients with HER2-negative metastatic breast cancer who have tumor progression after at least two, but not more than three, prior chemotherapy regimens.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Bennett Peter Scaglia, MD 311 N Clyde Morris Blvd Ste 480, Daytona Beach, FL 32114-2766 Ph: (386) 425-4199 | Dr Bennett Peter Scaglia, MD 311 N Clyde Morris Blvd, Suite 360, Daytona Beach, FL 32114-2781 Ph: (386) 254-4199 |
News Archive
A Michigan State University public health researcher is embarking on a first-of-a-kind study that will look to reduce suicides among recently released jail detainees.
The Green Bay CBS affiliate is reporting that the "Better Business Bureau is putting out an alert about health insurance related scams." Scammers have been more active since the health bill passed.
The Observer on Tuesday published a series of feature articles examining family planning in Uganda.
Cell Therapeutics, Inc. (CTI) today announced an agreement with the North Central Cancer Treatment Group (NCCTG) to conduct a phase II study of pixantrone in patients with HER2-negative metastatic breast cancer who have tumor progression after at least two, but not more than three, prior chemotherapy regimens.
› Verified 2 days ago
Shawn Wayne Thomas, D.O. Urology Medicare: Accepting Medicare Assignments Practice Location: 311 N Clyde Morris Blvd Ste 360, Daytona Beach, FL 32114 Phone: 386-254-4199 Fax: 386-947-4680 | |
Dr. Sean Tirney, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1925 S Atlantic Ave, Suite #609, Daytona Beach, FL 32118 Phone: 386-747-4240 | |
Michael Doughney Dineen, MD Urology Medicare: Medicare Enrolled Practice Location: 545 Health Blvd, Daytona Beach, FL 32114 Phone: 386-239-8500 | |
Benjamin T Brown, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 545 Health Blvd, Daytona Beach, FL 32114 Phone: 386-239-8500 | |
Dr. Charles E Womack, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 303 N Clyde Morris Blvd, Daytona Beach, FL 32114 Phone: 386-254-4199 Fax: 386-947-4680 | |
Dr. Tony L Cantwell, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 545 Health Blvd, Daytona Beach, FL 32114 Phone: 386-239-8500 |